Establishing secure connection…Loading editor…Preparing document…

Healthcare Pharmacovigilance Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE PHARMACOVIGILANCE REPORT

This form documents an adverse event, medication error, product quality complaint, or other safety information related to a medicinal product. Complete all applicable sections with factual, objective information. Submission of this report authorizes collection and processing of the information for pharmacovigilance and public safety purposes in accordance with applicable privacy protections.

Patient Information

Date of birth:    Gender: Male Female Other Unknown

Reporter Information

Reporter name:    Relationship to patient:

Reporter type: Patient Healthcare professional Manufacturer/Distributor Other

Suspected Product(s)

Active ingredient(s):    Manufacturer:

Batch/Lot number:    Expiry date:

Route of administration:    Dose and regimen:

Adverse Event Details

Date/time of onset:    Time to onset after exposure:

Seriousness (check all that apply): Death Life-threatening Hospitalization Persistent disability/incapacity Congenital anomaly Other

Outcome of event: Resolved Recovering Not resolved Fatal Unknown

Action taken with suspected product: Discontinued Dose reduced No change Unknown

Medical History and Investigations

Follow-up and Additional Information

Is follow-up required?    If yes, planned follow-up date:

Consent, Authorization and Certification

By submitting this report I certify that I am authorized to provide the information contained herein. I authorize collection, use and disclosure of the information for pharmacovigilance activities, including follow-up contact by clinicians or safety personnel to obtain additional clinical information. Information will be handled in accordance with applicable privacy requirements; personal identifiers will be used only as necessary for case assessment and follow-up.

I acknowledge that I may withdraw consent to further follow-up at any time by notifying the reporter contact provided above; withdrawal does not affect the processing of information already collected. I understand that accurate and complete information is necessary for appropriate safety assessment and public health action.

Authorization expiration date:

Patient/Reporter attestation: I attest that the information provided is accurate and complete to the best of my knowledge.

HIPAA/Privacy acknowledgment: I acknowledge receipt of the privacy information related to this report.    Initials:

Patient Printed Name:

Signature:

If signed by guardian, relationship:

Date:

Enter text✕

What the Healthcare Pharmacovigilance Document Is

A Healthcare Pharmacovigilance Document records suspected adverse events, medication errors, and safety signals related to medicinal products, biologics, or medical devices. It standardizes case-level data used for signal detection, aggregate safety assessment, and regulatory reporting to agencies such as FDA. Typical forms include individual case safety reports (ICSRs), expedited safety reports, and study safety summaries. The document captures patient identifiers, event description, drug exposure, clinical outcome, reporter details, and causality assessment to support follow-up, trend analysis, and compliance with statutory reporting obligations.

Why a Clear Pharmacovigilance Document Matters

A properly completed pharmacovigilance document ensures consistent capture of safety data, supports timely regulatory submissions, and reduces follow-up queries. Accurate records protect patients and help organizations meet statutory deadlines under FDA regulations and other oversight bodies while preserving an auditable trail for inspections.

Why a Clear Pharmacovigilance Document Matters

Typical Users and Stakeholders

Pharmacovigilance documents are used across clinical, regulatory, and commercial teams to collect and process safety information.

  • Pharmacovigilance teams: maintain case intake, triage, causality assessment, and regulatory submission workflows.
  • Clinical research sites: supply investigator reports and source information for clinical trial safety monitoring.
  • Regulatory affairs and quality: review aggregated data, prepare expedited reports, and manage agency communications.

Proper role alignment speeds review, reduces reporting delays, and clarifies responsibility for follow-up, escalation, and submission.

Step-by-step: Completing a Pharmacovigilance Document

Follow a consistent sequence: intake, verify, document, assess, escalate, and submit. Maintain an audit trail of every action.

  • 01
    Intake: Record initial reporter details and event summary immediately.
  • 02
    Verification: Confirm patient identity and product exposure details where available.
  • 03
    Assessment: Document severity, seriousness, and plausible causality.
  • 04
    Submission: Route to regulatory team for expedited reporting when required.

How to Configure an Electronic Pharmacovigilance Workflow

Set up authentication, routing, and retention rules before wide use to ensure regulatory readiness and secure access.

Field Configuration
Authentication Use SSO or SMS code for signer verification
Routing Automate sequential review by PV, clinical, then regulatory
Retention Apply 6-year HIPAA retention rules where applicable
Notifications Enable email and in-platform alerts for critical events

Typical Electronic Submission Flow

An e-submission workflow moves a case from intake to regulatory submission while preserving timestamps, attachments, and reviewer notes.

  • Upload: Attach source documents and initial report metadata.
  • Map Fields: Match form fields to safety database schema.
  • Authenticate: Verify reporter or reviewer identity before approval.
  • Submit: Create and store an auditable submission record.

Platform Capabilities and Integrations to Consider

Choose a platform that supports secure uploads, audit trails, and integrations with clinical and regulatory systems.

  • Integrations: Salesforce, NetSuite, Microsoft 365, Google Workspace
  • File formats: PDF, DOCX, CSV, XML supported
  • Authentication: SSO, SMS, and advanced signer controls

Key Data Elements and Security Controls

Patient Identifiers: Name, DOB, MRN
Clinical Details: Symptoms, onset, labs
Product Data: Manufacturer, lot, dose
Reporter Info: Name, role, contact
Audit Trail: Timestamps, IP, actions
Encryption: TLS 1.2/1.3; AES-256

Core Components of a Professional Pharmacovigilance Document

A robust template balances structured fields for regulatory data with free-text fields for clinical nuance; include attachments and version control.

Case Header

Identifies facility, reporter, case ID, and triage priority. This anchors downstream workflows and supports auditability.

Patient Data

Structured fields for demographics and identifiers to enable deterministic matching to medical records and safety databases.

Exposure History

Records suspected product, dose, start/stop dates, concomitant medications, and device details when applicable.

Event Narrative

Chronological clinical description, relevant labs, interventions, and outcomes to aid causality assessment and signal detection.

Seriousness Criteria

Standardized checkboxes for hospitalization, life-threatening event, disability, or death to trigger expedited reporting.

Attachments

Lab reports, discharge summaries, and images that substantiate the clinical assessment and support regulatory review.

Common Preparation Pitfalls to Avoid

  • Incomplete exposure dates: missing start/stop dates complicate causality assessments and can delay regulatory submission.
  • Vague event descriptions: nonclinical wording or absent timelines force follow-up and extend case processing time.
  • Incorrect patient identifiers: mismatched names or DOBs prevent matching to source records and may breach data integrity.
  • Unattached source documents: failing to include lab reports or discharge summaries increases query volume and review time.

Regulatory and Operational Risks

Regulatory fines: FDA enforcement possible
Delayed safety action: Patient risk increases
Data breaches: HIPAA violation exposures
Inspection findings: Audit remediation costs
Reputational harm: Loss of stakeholder trust
Submission rework: Increased operational burden

Regulatory Reporting Deadlines to Remember

Different events trigger different timelines; follow regulatory definitions for 'serious' and 'unexpected' to determine reporting windows.

Immediate Notification:

Report deaths and immediate life-threatening events without undue delay

7-Day Reports:

Fatal or life-threatening unexpected events under IND must be reported within 7 calendar days (21 CFR 312.32)

15-Day Reports:

Other serious unexpected events often require reporting within 15 calendar days to regulatory authorities

Periodic Safety Reports:

Aggregate periodic reports follow sponsor and agency-specific schedules

Local Reporting:

Institutional reporting timelines may be shorter than regulatory windows

Key Processing Milestones from Receipt to Submission

These stages describe the common lifecycle for a pharmacovigilance case from initial report through regulatory filing and archival.

01

1. Receipt and Logging

Capture initial data, assign case ID, and record intake timestamp.

02

2. Triage and Prioritization

Determine seriousness and need for expedited reporting.

03

3. Clinical Assessment

Perform causality review and request follow-up details as needed.

04

4. Regulatory Submission

Prepare ICSR or expedited report and submit to appropriate agency.

eSignature Pricing and Capability Comparison

This vendor comparison highlights starting prices and core capabilities relevant for pharmacovigilance workflows; consult each vendor for plan-specific details.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes (Business Premium) Varies by plan Varies by plan Varies by plan Varies by plan
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently Asked Questions and Troubleshooting

Answers to common questions about completion, signatures, privacy, and regulatory submission for pharmacovigilance records.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users